#Purdue Pharma


Purdue Pharma pleads guilty in case initiated by Vermont prosecutors

BURLINGTON, Vt. (WCAX) - Drugmaker Purdue Pharma, the company behind the powerful prescription painkiller OxyContin, pleaded guilty Wednesday to federal criminal charges as part of an $8 billion settlement. Vermont authorities played a major role in the case that resulted in charges that related to a kickback scheme aimed at...
Picture for Purdue Pharma pleads guilty in case initiated by Vermont prosecutors

Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over OxyContin Sales

The Justice Department announced on Wednesday a global settlement of civil and criminal investigations into Purdue Pharma's aggressive marketing of opioid medications, including OxyContin. Federal officials have long maintained Purdue's actions helped fuel a prescription opioid epidemic that has killed more than 232,000 Americans, according to the Centers for Disease...

Purdue Pharma Settles With U.S. DOJ Over Opioid Probes

Purdue Pharma LP has reached a $8.34 billion settlement with the U.S. Department of Justice (DOJ) to put an end to lengthy criminal and civil federal probes into its marketing and distribution practices regarding opioid painkillers, notably its OxyContin product. However, since the privately owned company has assets far below $8 billion, the settlement may be largely symbolic, although the controlling Sackler family will pay $225 million to resolve civil suits.
Washington Post

Purdue Pharma agrees to plead guilty to federal criminal charges in settlement over opioid crisis

The Justice Department announced a historic $8.3 billion settlement Wednesday with OxyContin-maker Purdue Pharma, capping a long-running federal investigation into the company that, for critics, became a leading symbol of corporations profiting from America’s deadly addiction to opioid painkillers. As part of the deal — the largest such settlement ever...

AMA statement on Justice Department settlement with Purdue Pharma

“The American Medical Association recommends that any settlement or judgment stemming from opioid-related litigation be used exclusively for data collection, research, education, overdose prevention, stigma elimination, and evidence-based treatment for substance use disorders and pain. “The nation now is facing a more complicated and deadly drug overdose epidemic due to...
The Guardian

Purdue Pharma nears guilty plea agreement over alleged role in opioids crisis

Purdue Pharma, the OxyContin prescription opioid painkiller maker controlled by members of the wealthy Sackler family, is nearing an agreement to plead guilty to criminal charges as part of a broader deal to resolve US justice department investigations into its alleged role in fueling the nation’s opioid crisis, six people familiar with the matter said.

Purdue Pharma's Predicament: AGs Want to Block Proposed Settlement With Justice Department

"That is not getting Purdue Pharma out of the business of selling opioids," Connecticut Attorney General William Tong said. Attorneys general from 24 states, including Connecticut, New York, New Jersey and California, and the District of Columbia have sent a letter to U.S. Attorney General William Barr asking that a proposed settlement between the U.S. Department of Justice and OxyContin maker Purdue Pharma not be finalized.
The New Yorker

The Sackler Family’s Plan to Keep Its Billions

The Trump Administration is poised to make a settlement with Purdue Pharma that it can claim as a victory for opioid victims. But the proposed outcome would leave the company’s owners enormously wealthy—and off the hook for good. This past January, the Justice Department announced the results of investigations into...
Hartford Courant

Connecticut joins other states in fight against efforts to preserve Purdue Pharma’s Oxycontin business as a public trust

Connecticut Attorney General William Tong joined two dozen attorneys general from across the country last week in opposition to a proposed U.S. Department of Justice settlement agreement with Stamford-based Purdue Pharma that would preserve its lucrative Oxycontin business as a public trust. The letter to U.S. Attorney General William Barr,...
New York Post

States oppose OxyContin maker Purdue Pharma’s settlement with DOJ

A group of 25 state attorneys general oppose a settlement of opioid probes being negotiated with Purdue Pharma and members of the wealthy Sackler family who own it, arguing the deal would improperly entangle state and local officials with future sales of the company’s addictive pain drug OxyContin. In a...